Volume 29, Issue 5 pp. 548-554

Biological characters of [18F]O-FEt–PIB in a rat model of Alzheimer's disease using micro-PET imaging1

Ming-qiang ZHENG

Ming-qiang ZHENG

Research Center of Radiopharmaceuticals, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China

Graduate School of the Chinese Academy of Sciences, Beijing 100049, China

Search for more papers by this author
Duan-zhi YIN

Corresponding Author

Duan-zhi YIN

Research Center of Radiopharmaceuticals, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China

Correspondence to Prof Duan-zhi YIN. Phn 86-21-5955-8507. Fax 86-21-5955-4696. E-mail [email protected]Search for more papers by this author
Lan ZHANG

Lan ZHANG

Research Center of Radiopharmaceuticals, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China

Search for more papers by this author
Bei LEI

Bei LEI

Department of Nuclear Medicine, Huashan Hospital, Fudan University, Shanghai 200040, China

Search for more papers by this author
Deng-feng CHENG

Deng-feng CHENG

Research Center of Radiopharmaceuticals, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China

Search for more papers by this author
Han-cheng CAI

Han-cheng CAI

Research Center of Radiopharmaceuticals, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China

Search for more papers by this author
Yan-jiang HAN

Yan-jiang HAN

Research Center of Radiopharmaceuticals, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China

Graduate School of the Chinese Academy of Sciences, Beijing 100049, China

Search for more papers by this author
Ming-xing WU

Ming-xing WU

Research Center of Radiopharmaceuticals, Shanghai Institute of Applied Physics, Chinese Academy of Sciences, Shanghai 201800, China

Graduate School of the Chinese Academy of Sciences, Beijing 100049, China

Search for more papers by this author
Hong ZHANG

Hong ZHANG

Department of Nuclear Medicine, The Second Affiliated Hospital, Zhejiang University, Hangzhou 310009, China

Search for more papers by this author
Jing WANG

Jing WANG

Zhejiang-California International Nanosystems Institute, Hangzhou 310009, China

Search for more papers by this author
1

Project supported by the Science Foundation of Shanghai (No 06DZ19506) and the National Natural Science Foundation of China (No 20601028).

Abstract

Aim: To evaluate whether the newly-synthesized positron emission tomography (PET) tracer, [18F]2-(4′-(methylamino)phenyl)-6-fluoroethoxy- benzothiazole ([18F] O-FEt-PIB), could bind to β-amyloid aggregates in a rat model of Alzheimer's disease (AD) using micro-PET. Method: [18F]O-FEt-PIB was synthesized and purified by radio HPLC. PET imaging was performed with a R4 rodent model scanner in 3 model and 3 control rats. Dynamic PET scans were performed for 40 min in each rat following an injection of approximately 37 MBq of [18F]O-FEt-PIB. Static scans were also performed for 15 min in each rat. PET data were reconstructed by a maximum posteriori probability algorithm. On the coronal PET images, regions of interest were respectively placed on the cortex, hemicerebrum [including the hippocampus and thalamus (HT)], and were guided by a 3-D digital map of the rat brain or the brain images of [18F]2-Deoxy-2-fluoro-JD-glucose ([18F]FDG) in normal rats. Time-activity curves (TAC) were obtained for the cerebrum and cerebellum. The activity difference value (ADV) between 2 hemicerebrums was also calculated. Results: The TAC for [18F]O-FEt-PIB in the cerebrum or cerebellum peaked early (at approximately 2 min), but washed out a little slowly. In the dynamic and static micro-PET images, increased radioactivity was found in the area of the right HT in the model rats where infused with β-amyloid (1–40). No distinct difference of radioactivity was found between the right and left HT areas in the control rats. The ADV(HT) was approximately 14.6% in the AD model rats and approximately 4 times greater than that of the control rats (3.9%). Conclusion: To our knowledge, this study is the first to evaluate a small molecular PET probe for the p-amyloid deposits in vivo using micro-PET imaging in an AD-injected rat model. The suitable biological characters showed that the tracer had potential to be developed as a probe for detecting β-amyloid plaques in AD.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.